To further confirm this expression pattern, we performed immunofluorescence staining in tumors from C57BL/6J mice implanted with CT2A cells, an AKT-activated GBM cell line possessing GSC-like phenotype (15, 17). This evidence concerns the gene AKT1 and glioblastoma.